Quote | SILO Pharma Inc (OTCMKTS:SILO)
Last: | $0.17 |
---|---|
Change Percent: | -1.43% |
Open: | $0.1775 |
Close: | $0.17 |
High: | $0.18 |
Low: | $0.17 |
Volume: | 87,553 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | SILO Pharma Inc (OTCMKTS:SILO)
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
Silo Pharma (NASDAQ: SILO) is a developmental-stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced that it has exercised its option to license SPC-15, a prophylactic...
Message Board Posts | SILO Pharma Inc (OTCMKTS:SILO)
Subject | By | Source | When |
---|---|---|---|
$SILO gaining traction on news #PTSD #Anxiety | Garbage2Gucci | investorshub | 04/20/2023 3:07:36 PM |
NetworkNewsWire: Silo Pharma Inc. (NASDAQ: SILO) Provides Update on Innovative Study Looking into th | NetworkNewsWire | investorshangout | 03/28/2023 8:42:36 PM |
NetworkNewsWire: NetworkNewsBreaks Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Fi | NetworkNewsWire | investorshangout | 03/27/2023 7:55:53 PM |
NetworkNewsWire: NetworkNewsBreaks Silo Pharma Inc. (NASDAQ: SILO) Positioned as Frontrunner in Psy | NetworkNewsWire | investorshangout | 03/24/2023 9:08:31 PM |
NetworkNewsWire: NetworkNewsBreaks Silo Pharma Inc. (NASDAQ: SILO) Announces Positive Results from | NetworkNewsWire | investorshangout | 03/15/2023 7:38:09 PM |
News, Short Squeeze, Breakout and More Instantly...
SILO Pharma Inc Company Name:
SILO Stock Symbol:
OTCMKTS Market:
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
Exclusive license for development, manufacturing, and commercialization in process Silo Pharma to file Pre-IND in first half 2024 SARASOTA, FL, Ma...
Silo Pharma (NASDAQ: SILO) is a developmental-stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced that it has exercised its option to license SPC-15, a prophylactic...